title: Spotlight on platelets: summary of BBTS combined special interest group autumn meeting, November 2015.
abstract: This conference first addressed aspects of component quality, highlighting the role of pathogen inactivation, the role of PAS or plasma in prolonging platelet viability and acceptable storage deviations. A series of talks on the medical use of platelets covered the role of platelet transfusion in preventing intracranial haemorrhage, platelet prophylaxis in haematological patients and the new trial of the HLA Matchmaker programme to provide epitope-matched platelets. The session on the surgical use of platelets considered the role of platelet transfusions in patients on anti-platelet agents, major trauma and interventional procedures and also the scope for tests of platelet function to direct therapy. The conference concluded with a panel discussion highlighting key areas of general interest, including the clinical use of platelets and near patient platelet function tests.
authors.affiliation: NHS Blood & Transplant, England.|Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, England.|University of Oxford, Oxford, UK.
authors.forename: M F
authors.initials: MF
authors.lastname: Murphy
authors.affiliation: University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
authors.forename: R
authors.initials: R
authors.lastname: Gill
authors.affiliation: NHS Blood & Transplant, England.|Imperial College Healthcare NHS Trust, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Moss
authors.affiliation: University Hospitals Birmingham NHS Foundation Trust, England.
authors.forename: M
authors.initials: M
authors.lastname: Raghavan
authors.affiliation: NHS Blood & Transplant, England.|Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, England.|University of Oxford, Oxford, UK.
authors.forename: S J
authors.initials: SJ
authors.lastname: Stanworth
authors.affiliation: NHS Blood & Transplant, England.|Imperial College Healthcare NHS Trust, London, UK.
authors.forename: M
authors.initials: M
authors.lastname: Rowley
authors.affiliation: Newcastle Upon Tyne NHS Foundation Trust, England.
authors.forename: J
authors.initials: J
authors.lastname: Wallis
mesh_terms: D001792:Blood Platelets / Q000378:metabolism*; D001793:Blood Preservation / Q000009:adverse effects / Q000379:methods*; D002470:Cell Survival; D003226:Congresses as Topic; D006650:Histocompatibility Testing / Q000379:methods; D006801:Humans; D020300:Intracranial Hemorrhages / Q000097:blood / Q000473:pathology / Q000517:prevention & control*; D010949:Plasma; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D010979:Platelet Function Tests / Q000379:methods; D017713:Platelet Transfusion / Q000379:methods*; D014947:Wounds and Injuries / Q000097:blood / Q000473:pathology / Q000628:therapy*
chemical_list: D010975:Platelet Aggregation Inhibitors
keywords: BBTS; meeting report; platelets